SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 373 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,007 | -49.1% | 14,561 | -52.1% | 0.03% | -60.3% |
| Q4 2022 | $3,941 | -99.9% | 30,412 | -13.7% | 0.08% | -7.1% |
| Q3 2022 | $3,896,000 | +1039.2% | 35,248 | +704.2% | 0.08% | +950.0% |
| Q1 2022 | $342,000 | +40.7% | 4,383 | +62.3% | 0.01% | +100.0% |
| Q4 2021 | $243,000 | -94.5% | 2,701 | -95.2% | 0.00% | -95.2% |
| Q2 2021 | $4,405,000 | +812.0% | 56,657 | +773.8% | 0.08% | +730.0% |
| Q1 2021 | $483,000 | +0.8% | 6,484 | +130.6% | 0.01% | -28.6% |
| Q4 2020 | $479,000 | -78.7% | 2,812 | -80.0% | 0.01% | -87.5% |
| Q2 2020 | $2,250,000 | -58.2% | 14,034 | -65.6% | 0.11% | -40.4% |
| Q2 2018 | $5,388,000 | +480.6% | 40,761 | +48.1% | 0.19% | +571.4% |
| Q2 2017 | $928,000 | -61.3% | 27,517 | -66.0% | 0.03% | -62.2% |
| Q1 2017 | $2,395,000 | -81.9% | 80,929 | -62.5% | 0.07% | -76.2% |
| Q3 2016 | $13,260,000 | +1617.6% | 215,933 | +798.1% | 0.31% | +1096.2% |
| Q3 2015 | $772,000 | – | 24,042 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |